作者:Katrin Groebke Zbinden、David W. Banner、Jean Ackermann、Allan D’Arcy、Daniel Kirchhofer、Yu-Hua Ji、Thomas B. Tschopp、Sabine Wallbaum、Lutz Weber
DOI:10.1016/j.bmcl.2004.10.092
日期:2005.2
Proof of concept experiments have shown that tissue factor/factor Vila inhibitors have antithrombotic activity without enhancing bleeding propensity. Starting from lead compounds generated by a biased combinatorial approach, phenylglycine amide tissue factor/factor Vila inhibitors with low nanomolar affinity and good selectivity against other serine proteases of the coagulation cascade were designed, using the guidance of X-ray structural analysis and molecular modelling. (C) 2004 Elsevier Ltd. All rights reserved.